A two-decade bibliometric analysis of drug resistance in oral cancer research: patterns, trends, and future directions

被引:0
作者
Xu, Xuejin [1 ]
Wang, Zhen [1 ]
机构
[1] Wenzhou Med Univ, Quzhou Peoples Hosp, Dept Stomatol, Quzhou Affiliated Hosp, Minjiang Ave 100, Quzhou 332400, Zhejiang, Peoples R China
关键词
Oral cancer drug resistance; Bibliometrics; CiteSpace; Web of Science; SQUAMOUS-CELL CARCINOMA; CISPLATIN RESISTANCE;
D O I
10.1007/s12672-025-02225-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundDrug resistance in oral cancer presents a significant challenge in clinical treatment. Understanding the research landscape through bibliometric analysis can provide valuable insights into the development and trends in this field.ObjectiveTo comprehensively analyze the global research trends, collaboration patterns, and emerging topics in oral cancer drug resistance research from 2000 to 2024 using bibliometric methods.MethodsPublications related to oral cancer drug resistance were retrieved from the Web of Science core collection database. CiteSpace and VOSviewer were employed to analyze publication trends, research collaboration networks, and keyword co-occurrence patterns. The analysis included annual publication outputs, country contributions, institutional productivity, author collaborations, journal distributions, and research hotspots.ResultsA total of 971 publications were identified, showing a significant increase in research output over the study period, particularly after 2014. China led in publication output (485 articles), followed by Japan (130 articles) and the United States (118 articles). China Medical University was the most productive institution (50 publications). The International Journal of Molecular Sciences, Cancers, and Oral Oncology were the primary publishing venues. Keyword analysis revealed an evolution from basic drug resistance mechanisms to emerging research areas including cancer stem cells, tumor microenvironment, and extracellular vesicles.ConclusionsThis bibliometric analysis demonstrates the rapid growth and evolving nature of oral cancer drug resistance research. The findings highlight the shift towards more sophisticated research areas and strong international collaboration patterns. These insights can guide future research directions and collaboration opportunities in this field.
引用
收藏
页数:20
相关论文
共 43 条
[1]   Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges [J].
Acharya, Surendra Kumar ;
Shai, Saptarsi ;
Choon, Yee Fan ;
Gunardi, Indrayadi ;
Hartanto, Firstine Kelsi ;
Kadir, Kathreena ;
Roychoudhury, Ajoy ;
Amtha, Rahmi ;
Vincent-Chong, Vui King .
BIOMEDICINES, 2024, 12 (09)
[2]   Potential role of heteroplasmic mitochondrial DNA mutations in modulating the subtype-specific adaptation of oral squamous cell carcinoma to cisplatin therapy [J].
Aminuddin, Amnani ;
Ng, Pei Yuen ;
Leong, Chee Onn ;
Makpol, Suzana ;
Chua, Eng Wee .
DISCOVER ONCOLOGY, 2024, 15 (01)
[3]  
Atashi Fatemeh, 2021, J Dent Res Dent Clin Dent Prospects, V15, P219, DOI 10.34172/joddd.2021.036
[4]   Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers? [J].
Bucci-Munoz, Maria ;
Gola, Aldana Magali ;
Rigalli, Juan Pablo ;
Ceballos, Maria Paula ;
Ruiz, Maria Laura .
LIFE-BASEL, 2023, 13 (08)
[5]   Interplay of p62-mTORC1 and EGFR signaling promotes cisplatin resistance in oral cancer [J].
Chang, Hsiu-Chuan ;
Yang, Cheng-Chieh ;
Loi, Lai-Keng ;
Hung, Chi-Hsun ;
Wu, Cheng-Hsien ;
Lin, Yu-Cheng .
HELIYON, 2024, 10 (06)
[6]  
Cutilli T, 1997, Minerva Stomatol, V46, P671
[7]  
Gupta Neha, 2024, J Oral Maxillofac Pathol, V28, P284, DOI 10.4103/jomfp.jomfp_345_23
[8]   Decoding the research landscape of drug resistance and therapeutic approaches in head and neck cancer: a bibliometric analysis from 2000 to 2023 [J].
Han, Qi ;
Shi, Junqi ;
Liu, Jiaojiao ;
Fu, Yang ;
Li, Zhongxun ;
Guo, Huina ;
Guan, Xiaoya ;
Xue, Xuting ;
Liu, Hongliang ;
Zhao, Liting ;
Zhang, Chunming .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[9]   The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma [J].
He, Di ;
Xu, Qin ;
Yan, Ming ;
Zhang, Ping ;
Zhou, Xiaojian ;
Zhang, Zhiyuan ;
Duan, Wenhu ;
Zhong, Laiping ;
Ye, Dongxia ;
Chen, Wantao .
BMC CANCER, 2009, 9 :343
[10]   Deep learning-based automatic image classification of oral cancer cells acquiring chemoresistance in vitro [J].
Hsieh, Hsing-Chuan ;
Chen, Cho-Yi ;
Chou, Chung-Hsien ;
Peng, Bou-Yue ;
Sun, Yi-Chen ;
Lin, Tzu-Wei ;
Chien, Yueh ;
Chiou, Shih-Hwa ;
Hung, Kai-Feng ;
Lu, Henry Horng-Shing .
PLOS ONE, 2024, 19 (11)